Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Growth Metrics

Others

Marimed (MRMD) Land & Improvements (2016)

Marimed (MRMD) has disclosed Land & Improvements for 2 consecutive years, with $686802.0 as the latest value for Q3 2016.

On a quarterly basis, Land & Improvements changed N/A to $686802.0 in Q3 2016 year-over-year; TTM through Sep 2016 was $686802.0, a N/A change, with the full-year FY2015 number at $71488.0, changed N/A from a year prior.
Land & Improvements was $686802.0 for Q3 2016 at Marimed, up from $179196.0 in the prior quarter.
In the past five years, Land & Improvements ranged from a high of $686802.0 in Q3 2016 to a low of $71488.0 in Q4 2015.